These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Arterial infusion chemotherapy for patients with advanced and moderately advanced cancer of urinary bladder].
    Author: Li Q, Xu X, Liu J.
    Journal: Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):308-9. PubMed ID: 10920993.
    Abstract:
    OBJECTIVE: To study the effect of arterial infusion chemotherapy in patients with carcinoma of urinary bladder. METHODS: Eleven patients with advanced or moderately advanced cancer of the urinary bladder (10 transitional cell carcinoma, 1 squamous-cell carcinoma) who were for various reasons not suitable for surgical treatment were treated by arterial infusion chemotherapy according to Seldinger's percutaneous approach. RESULTS: The treatment results were satisfactory with an overall response rate of 90.9% (CR = 2, PR = 8). The average survival time of the 11 patients was 26.2 +/- 13.1 months. The 1-year survival rate was 81.8%. Side effects were mild. CONCLUSION: Arterial infusion chemotherapy is of use in patients with advanced or moderately advanced bladder cancer.
    [Abstract] [Full Text] [Related] [New Search]